Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
Pre-market 01:08:45 | |||
| 173.80 EUR | +0.52% |
|
174.25 | +0.26% |
| 07-28 | SARTORIUS STEDIM BIOTECH : Buy rating from Bernstein | ZD |
| 07-24 | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| Market Cap | 16.91B 19.52B 15.76B 14.5B 27.37B 1,857B 27.68B 185B 72.7B 929B 73.33B 71.71B 3,076B | P/E 2026 * |
44.8x | P/E 2027 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise Value | 18.92B 21.85B 17.64B 16.22B 30.63B 2,077B 30.97B 207B 81.35B 1,039B 82.05B 80.24B 3,442B | EV / Sales 2026 * |
6.05x | EV / Sales 2027 * | 5.39x |
| Free-Float |
28.47% | Yield 2026 * |
0.49% | Yield 2027 * | 0.59% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +0.52% | ||
| 1 week | +1.52% | ||
| Current month | +4.26% | ||
| 1 month | -3.55% | ||
| 3 months | +7.02% | ||
| 6 months | -4.19% | ||
| Current year | -17.24% |
| 1 week | 166 |  | 175.5 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.52% | +1.52% | +2.30% | -35.53% | 19.52B | |
| +0.24% | -2.12% | -19.11% | -1.80% | 183B | |
| -0.24% | -1.77% | -4.10% | +2.32% | 110B | |
| +3.57% | -0.44% | +8.51% | +71.16% | 61.72B | |
| -2.72% | +5.66% | +34.85% | +50.75% | 54.98B | |
| +0.32% | +1.34% | -3.52% | -36.98% | 47.02B | |
| -12.79% | -8.52% | - | - | 32.16B | |
| -4.92% | +10.01% | +9.54% | -31.31% | 31.19B | |
| +0.65% | +4.02% | +46.96% | -6.41% | 24.7B | |
| -0.06% | -0.90% | +3.95% | +2.96% | 22.68B | |
| Average | -1.54% | +1.41% | +8.82% | +1.69% | 58.7B | |
| Weighted average by Cap. | -0.75% | +0.24% | -0.14% | +6.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.61B 2.91B 2.68B 5.06B 343B 5.12B 34.24B 13.44B 172B 13.55B 13.26B 569B | 3.47B 4B 3.23B 2.97B 5.61B 380B 5.67B 37.96B 14.9B 190B 15.03B 14.7B 631B |
| Net income | 376M 434M 351M 323M 609M 41.31B 616M 4.12B 1.62B 20.67B 1.63B 1.6B 68.45B | 480M 555M 448M 412M 778M 52.75B 786M 5.26B 2.07B 26.39B 2.08B 2.04B 87.41B |
| Net Debt | 2.01B 2.32B 1.87B 1.72B 3.26B 221B 3.29B 22.03B 8.65B 110B 8.72B 8.53B 366B | 1.77B 2.04B 1.65B 1.52B 2.86B 194B 2.89B 19.38B 7.6B 97.17B 7.67B 7.5B 322B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | €173.80 | +0.52% | 62,230 |
| 26-08-04 | €172.90 | +0.58% | 74,728 |
| 26-08-03 | €171.90 | +3.12% | 65,593 |
| 26-07-31 | €166.70 | -2.00% | 137,690 |
| 26-07-30 | €170.10 | -0.64% | 57,064 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
